• It aims at producing entry- and mid-level scientists with the knowledge and skills appropriate for professional practice in translational research, with particular emphasis on the area of transition between early-stage preclinical drug discovery and clinical drug development. This area, commonly referred to as the “valley of death,” represents one of the most challenging and important areas in translational research, yet programs designed to train and educate future translational science leaders are lacking.
  • This program will allow them to design, critically evaluate, and optimize broad drug development strategies from the earliest stages of drug design and discovery to their application in patents and marketing. Depending on your interest, additional courses could focus on strategic, policy and regulatory aspects of drug development.